NEXT Molecular

NEXT Molecular Analytics, operating as NEXT Bio Research Services, LLC, is a contract research organization providing integrated research, development, and clinical testing services. The company serves physicians, long-term care facilities, and life science investigators across biotechnology and pharmaceutical companies, academic institutions, and government agencies. Its offerings include clinical services, contract research, support for FDA validation of specific assays, and consulting services. The organization also provides order forms and supporting documents for its services.

NEXT Molecular Analytics aims to deliver essential research and clinical support through innovative, cost-effective solutions. It emphasizes service, reliability, safety, and cost containment, while placing patient health, safety, and privacy at the center of its work. Its published research includes topics such as microsatellite instability analysis in bladder cancer and pharmacogenomics of CYP450 genes. The company is based in Chester, Virginia, and provides contact options for inquiries and career opportunities. Through its combination of laboratory testing, research support, and regulatory validation assistance, NEXT Molecular Analytics works with clinical and scientific organizations seeking specialized molecular analysis and related services.